AngioDynamics (ANGO) Reports 2.5M Share Secondary Offering of Common Stock by Holders

November 14, 2016 4:10 PM EST

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

AngioDynamics, Inc. (NASDAQ: ANGO) (the “Company”), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that certain of its stockholders (the “Selling Stockholders”) intend to offer for sale in an underwritten secondary offering 2,500,000 shares of common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), of which the Company intends to repurchase from the underwriter 500,000 shares of common stock. The Selling Stockholders will receive all of the net proceeds from this offering. No shares are being sold by the Company. Barclays Capital Inc. will act as underwriter for the offering.

A shelf registration statement (including a prospectus) relating to the offering of common stock was filed with the SEC on October 3, 2013 and became effective on October 11, 2013.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Equity Offerings

Related Entities


Add Your Comment